• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by EMulate Therapeutics Inc

News headline image
EMulate Therapeutics Announces Promotion of Kyle Kingma to SVP, Finance, and GM, EMulate Subsidiaries - Corporate Update Announcement
May 10, 2022
From EMulate Therapeutics Inc
Via AccessWire
Topics Initial Public Offering
News headline image
EMulate Therapeutics Named 50 Leading Companies of the Year for 2022 by The Silicon Review
March 29, 2022
From EMulate Therapeutics Inc
Via AccessWire
Tickers TSX-V:HAPB
News headline image
EMulate Therapeutics Announces Issuance Of 41st Patent Covering The Design Of A Pediatric Therapeutic Device For Cancer And Other Health Indications
March 07, 2022
From EMulate Therapeutics Inc
Via AccessWire
Topics Intellectual Property
News headline image
EMulate Therapeutics 2021 Year in Review - A Pivotal Year for the Company
February 01, 2022
From EMulate Therapeutics Inc
Via AccessWire
Tickers TSX-V:HAPB
News headline image
EMulate Therapeutics Announces Poster Presentation of Its Confirmatory Pre-Clinical Pain Study Results at the 15th Annual Pain Therapeutic Summit at Washington, D.C. (Nov 1-3)
October 29, 2021
From EMulate Therapeutics Inc
Via AccessWire
News headline image
EMulate Therapeutics Announces Positive, Confirmatory Pre-Clinical Data for its ulRFE(R) Technology Targeting Acute and Chronic Pain; Excellent Pain Reducing Effects Without the Use of Chemicals or Drugs
October 20, 2021
From EMulate Therapeutics Inc
Via AccessWire
News headline image
EMulate Therapeutics Announces Positive Pre-Clinical Data in Mental Health Models and First in Human Experience Using its Proprietary Radio Frequency Energy Technology; Preliminary Results Emulate Drug Effects in Rodent Models and in Human Exposures
October 05, 2021
From EMulate Therapeutics Inc
Via AccessWire
News headline image
EMulate Therapeutics Announces Issuance of Additional U.S. Patent Covering a Therapeutic Device for Cancer and Other Health Indications
September 28, 2021
From EMulate Therapeutics Inc
Via AccessWire
Topics Intellectual Property
News headline image
EMulate Therapeutics Announces Positive Pre-Clinical Data for its ulRFE(R) Technology Targeting Acute and Chronic Pain; Demonstrates Excellent Pain Reducing Effects Without the Use of Chemicals or Drugs
September 21, 2021
From EMulate Therapeutics Inc
Via AccessWire
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap